Comparative Pharmacology
Head-to-head clinical analysis: ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE versus FAMOTIDINE CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE versus FAMOTIDINE CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE.
ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE vs FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Aluminum hydroxide and magnesium trisilicate act as antacids by neutralizing gastric hydrochloric acid, increasing gastric pH, and inhibiting pepsin activity. Aluminum hydroxide forms aluminum phosphate in the intestine. Magnesium trisilicate reacts with HCl to form magnesium chloride and silicic acid, which may provide additional protective coating.
Famotidine is a competitive histamine H2-receptor antagonist that inhibits gastric acid secretion by blocking H2 receptors on parietal cells. Calcium carbonate and magnesium hydroxide act as antacids, neutralizing gastric acid via chemical neutralization.
10-20 mL (of suspension containing 200 mg aluminum hydroxide and 200 mg magnesium trisilicate per 5 mL) orally 1 hour after meals and at bedtime, up to 4 times daily.
1 tablet (famotidine 10 mg, calcium carbonate 800 mg, magnesium hydroxide 165 mg) orally once or twice daily as needed for heartburn; maximum 2 tablets in 24 hours.
None Documented
None Documented
Aluminum: terminal half-life in patients with normal renal function is approximately 8 hours for absorbed fraction, but may extend to days in renal failure. Magnesium: half-life of absorbed magnesium is 4-6 hours. Clinical context: accumulation risk in chronic kidney disease.
Famotidine: 2.5-3.5 hours (prolonged in renal impairment, up to 20 hours when CrCl <10 mL/min).
Aluminum and magnesium ions are minimally absorbed. Absorbed aluminum is primarily excreted renally (elimination half-life prolonged in renal impairment); unabsorbed components are eliminated in feces. Magnesium trisilicate may dissociate; absorbed magnesium is excreted renally. Fecal elimination accounts for >95% of the dose.
Famotidine: renal (65-70% unchanged), biliary/fecal (30-35%). Calcium carbonate: feces (unabsorbed calcium), urine (absorbed). Magnesium hydroxide: feces (unabsorbed magnesium), urine (absorbed).
Category C
Category A/B
Antacid
Antacid / Laxative